GLP-1 receptor agonists and antipsychotic-associated weight gain in child and adolescent psychiatry: a review of emerging evidence

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

BackgroundSecond-generation antipsychotics (SGAs) are commonly prescribed to children and adolescents but are associated with substantial weight gain and cardiometabolic dysfunction. Youth may be particularly vulnerable to these adverse effects, while available pharmacologic interventions remain limited. Metformin, the most studied treatment for antipsychotic-associated weight gain in pediatric…

Read original article on Frontiers in Psychiatry | New and Recent Articles →